Irf Reputation Ag

Irf Reputation Ag company information, Employees & Contact Information

IRF is a leading consultancy firm for strategic communications. IRF's core business is to build and protect the reputation of companies and exposed individuals. Reputation is the driving force behind our daily work, it sits at the very core of each business activity. We advise companies, business organizations, regulatory agencies and professional associations as well as high-profile individuals. Also, we maintain a broad network of contacts with the media and opinion leaders from academics and business. IRF offers tailor-made communication solutions for the service areas of media and investor relations, reputation management, public affairs, crisis and digital communication, corporate reporting and many more. From strategy consulting to the conception and implementation of individual action plans. IRF’s established customer base includes about 30 Swiss and international companies. IRF is the exclusive Swiss Affiliate Partner of FTI Consulting. Thanks to its close cooperation with FTI Consulting, IRF has extensive experience in managing international communications projects. Pragmatic, clever and effective: these three words aptly describe our company and the work we do. #IRF #WeBuildReputations
Looking for a particular Irf Reputation Ag employee's phone or email?

Irf Reputation Ag Questions

News

Ad hoc - Temenos publishes its 2025 Interim Report - Temenos

Ad hoc - Temenos publishes its 2025 Interim Report Temenos

Newron Pharmaceuticals to Participate in a Fireside Chat at the 37th Annual ROTH Conference - Business Wire

Newron Pharmaceuticals to Participate in a Fireside Chat at the 37th Annual ROTH Conference Business Wire

Temenos Announces Completion of its 2025 Share Buyback Program - Temenos

Temenos Announces Completion of its 2025 Share Buyback Program Temenos

FoRx Therapeutics Appoints Chief Medical Officer and Provides an Update on Its Lead Development Candidate - Business Wire

FoRx Therapeutics Appoints Chief Medical Officer and Provides an Update on Its Lead Development Candidate Business Wire

Ad hoc - Temenos Announces CEO Transition - Temenos

Ad hoc - Temenos Announces CEO Transition Temenos

Temenos announces closing of new USD 500m Revolving Credit Facility - Temenos

Temenos announces closing of new USD 500m Revolving Credit Facility Temenos

Temenos announces the publication of the agenda for its 2025 Annual General Meeting of Shareholders - Temenos

Temenos announces the publication of the agenda for its 2025 Annual General Meeting of Shareholders Temenos

Newron to Present New Analyses From and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 38th European College of Neuropsychopharmacology (ECNP) Congress 2025 - Business Wire

Newron to Present New Analyses From and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 38th European College of Neuropsychopharmacology (ECNP) Congress 2025 Business Wire

Ad hoc - Temenos announces new share buyback program of up to CHF 200m - Temenos

Ad hoc - Temenos announces new share buyback program of up to CHF 200m Temenos

Newron presents H1 2025 results and provides business update - Business Wire

Newron presents H1 2025 results and provides business update Business Wire

Ad hoc - Temenos announces new share buyback program of up to CHF 250m - Temenos

Ad hoc - Temenos announces new share buyback program of up to CHF 250m Temenos

SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire

SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine Business Wire

Ad hoc - Temenos completes the sale of Multifonds - Temenos

Ad hoc - Temenos completes the sale of Multifonds Temenos

Temenos announces the results of its 2025 Annual General Meeting of Shareholders - Temenos

Temenos announces the results of its 2025 Annual General Meeting of Shareholders Temenos

Ad hoc - Temenos Announces the Sale of Multifonds for About USD 400 Million - Temenos

Ad hoc - Temenos Announces the Sale of Multifonds for About USD 400 Million Temenos

Ad hoc - Temenos announces new strategic plan and FY-28 targets - Temenos

Ad hoc - Temenos announces new strategic plan and FY-28 targets Temenos

Temenos Announces Q1-25 Results; Solid Growth in ARR, EBIT and FCF - Temenos

Temenos Announces Q1-25 Results; Solid Growth in ARR, EBIT and FCF Temenos

Ad hoc - Temenos response to recent research report - Temenos

Ad hoc - Temenos response to recent research report Temenos

Ad hoc - Temenos announces preliminary Q4 and FY-24 results; ARR and TSL at top end of guidance, EBIT and FCF above guidance - Temenos

Ad hoc - Temenos announces preliminary Q4 and FY-24 results; ARR and TSL at top end of guidance, EBIT and FCF above guidance Temenos

Ad Hoc - Temenos announces new mid-term targets - Temenos

Ad Hoc - Temenos announces new mid-term targets Temenos

SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones - The AI Journal

SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones The AI Journal

Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS) - Business Wire

Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS) Business Wire

Ad hoc - Temenos announces completion of independent examination and publication of report - Temenos

Ad hoc - Temenos announces completion of independent examination and publication of report Temenos

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City - Business Wire

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City Business Wire

SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol "SHLT" - PR Newswire

SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol "SHLT" PR Newswire

SHL Telemedicine Announces Official Launch of SmartHeart - Business Wire

SHL Telemedicine Announces Official Launch of SmartHeart Business Wire

Ad hoc - Temenos announces appointment of independent third parties - Temenos

Ad hoc - Temenos announces appointment of independent third parties Temenos

Ad hoc - Temenos announces Chief Executive Officer appointment of Jean-Pierre Brulard - Temenos

Ad hoc - Temenos announces Chief Executive Officer appointment of Jean-Pierre Brulard Temenos

Temenos Announces New 2025 Targets - Temenos

Temenos Announces New 2025 Targets Temenos

Ad hoc - Temenos Announces Q1-24 Results; Strong Profitability and Free Cash Flow Growth - Temenos

Ad hoc - Temenos Announces Q1-24 Results; Strong Profitability and Free Cash Flow Growth Temenos

Cancellation of remaining publicly held registered shares of Vifor Pharma AG - Business Wire

Cancellation of remaining publicly held registered shares of Vifor Pharma AG Business Wire

Mbanq Signs with Temenos to Launch World’s First Credit Union - Temenos

Mbanq Signs with Temenos to Launch World’s First Credit Union Temenos

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024 - The AI Journal

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024 The AI Journal

Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care - The AI Journal

Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care The AI Journal

Extension of the postponement of the settlement of Vifor Pharma tender offer - Business Wire

Extension of the postponement of the settlement of Vifor Pharma tender offer Business Wire

CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd. - Business Wire

CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd. Business Wire

Temenos Appoints President and Chief Revenue Officer to Accelerate Growth - Temenos

Temenos Appoints President and Chief Revenue Officer to Accelerate Growth Temenos

Finalization of Vifor Pharma acquisition - Business Wire

Finalization of Vifor Pharma acquisition Business Wire

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024 - FinancialContent

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024 FinancialContent

Investor Relations - Temenos

Investor Relations Temenos

Temenos Strengthens Its Executive Committee to Accelerate Its Business Growth - Temenos

Temenos Strengthens Its Executive Committee to Accelerate Its Business Growth Temenos

Top Irf Reputation Ag Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant